My watch list
my.bionity.com  

my.bionity.com

With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.

  • My watch list
  • My saved searches
  • My saved topics
  • My newsletter
Register free of charge
Login  
eng  
DeutschEnglishFrançaisEspañol

Unigene Laboratories



Unigene Laboratories
Public
Founded1980
Headquarters
Key peopleWarren Levy, president & CEO
James Gilligan, vice president, product development
IndustryBiotechnology
Employees85 (2007)
Websitehttp://www.unigene.com


Unigene Laboratories (OTC:UGNE) is a biopharmaceutical company, engaged in the research and development of peptides for medical purposes. The company was founded in 1980 and is located in New Jersey.

The company's primary focus is on the development of calcitonin and related peptides for the treatment of osteoporosis. The company has licensed worldwide rights to its oral parathyroid hormone ("PTH") to GlaxoSmithKline.

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Unigene_Laboratories". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE